Anti-citrullinated histone monoclonal antibody CIT-013, a dual action therapeutic for neutrophil extracellular trap-associated autoimmune diseases

Author(s):
Linden, M. van der; Kumari, S.; Montizaan, D.; Dalen, S. van; Kip, A.; Foster, M.; Reinieren-Beeren, I.; Neubert, E. (0000-0003-4642-9112); Erpenbeck, L.; Waaijenberg, K.; Bruurmijn, T.; Poele, R. te; Zandvoort, P. van; Vink, P.; Meldrum, E.; Es, H. van; Chirivi, R.G.S.
Published
2023
Publication type
Article / Letter to editor
Citrullinated histonesMechanism of neutrophil extracellular trap inhibitionNeutrophil extracellular trap phagocytosisRheumatoid arthritisTherapeutic monoclonal antibod
Date issued
2023-11-29
Language
English
Is part of
mAbs (2023), No. 1, 2281763
hdl
1887/4252209
doi
10.1080/19420862.2023.2281763